USD/JPY: Early hike risk grows with 160 test – Standard Chartered
Standard Chartered’s Nicholas Chia and Chong Hoon Park note that new Bank of Japan (BoJ) data show underlying inflation near or above target and a positive output gap, while USD/JPY testing 160 raises the risk of earlier rate hikes than their current Q3 baseline. They also highlight that market pricing for roughly two BoJ hikes by December has remained stable.
USD/JPY pressures BoJ policy timing
"USD/JPY testing 160 raises the risk of the BoJ hiking earlier than our Q3 call. But there is still a high hurdle for the BoJ to meet market expectations of two rate hikes in 2026."
"At face value, the new indicators imply the BoJ may be falling behind the curve given above-target inflation, a positive output gap and a still-accommodative policy stance, proxied by a benchmark rate (0.75%) below the neutral rate range."
"This could explain bear steepening in the 2Y/10Y Japanese government bond (JGB) spread since the outbreak of the war to reflect lingering inflation risks from higher fuel costs."
"This is in contrast to 2Y/10Y spreads mostly bear flattening in other developed markets as policy rate hikes get priced back in on the recent oil price shock."
"Market pricing of roughly two BoJ hikes by December has also been remarkably stable in March."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
